Anushua Sinha

1.8k total citations
48 papers, 1.1k citations indexed

About

Anushua Sinha is a scholar working on Epidemiology, Health and General Health Professions. According to data from OpenAlex, Anushua Sinha has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 11 papers in Health and 8 papers in General Health Professions. Recurrent topics in Anushua Sinha's work include Pneumonia and Respiratory Infections (21 papers), Vaccine Coverage and Hesitancy (11 papers) and Respiratory viral infections research (10 papers). Anushua Sinha is often cited by papers focused on Pneumonia and Respiratory Infections (21 papers), Vaccine Coverage and Hesitancy (11 papers) and Respiratory viral infections research (10 papers). Anushua Sinha collaborates with scholars based in United States, Brazil and United Kingdom. Anushua Sinha's co-authors include Louise B. Russell, Richard Platt, Tracy A. Lieu, Maria Deloria Knoll, Orin S. Levine, Farzana Muhib, Mangala Rajan, Jennifer R. Verani, Stephanie J. Schrag and Deborah S. Yokoe and has published in prestigious journals such as The Lancet, Diabetes Care and PEDIATRICS.

In The Last Decade

Anushua Sinha

45 papers receiving 1.0k citations

Peers

Anushua Sinha
Angela Rose Barbados
Sarah Schillie United States
Vincent I. Ahonkhai United States
Mary Catlin United States
Patti Benson United States
Anushua Sinha
Citations per year, relative to Anushua Sinha Anushua Sinha (= 1×) peers José Cássio de Moraes

Countries citing papers authored by Anushua Sinha

Since Specialization
Citations

This map shows the geographic impact of Anushua Sinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anushua Sinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anushua Sinha more than expected).

Fields of papers citing papers by Anushua Sinha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anushua Sinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anushua Sinha. The network helps show where Anushua Sinha may publish in the future.

Co-authorship network of co-authors of Anushua Sinha

This figure shows the co-authorship network connecting the top 25 collaborators of Anushua Sinha. A scholar is included among the top collaborators of Anushua Sinha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anushua Sinha. Anushua Sinha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sinha, Anushua, Radha Railkar, Luis A. Castagnini, et al.. (2025). Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials. Contemporary Clinical Trials. 157. 107995–107995. 3 indexed citations
2.
Sinha, Anushua, et al.. (2022). Cervical cancer screening guidelines and screening practices in 11 countries: A systematic literature review. Preventive Medicine Reports. 28. 101813–101813. 49 indexed citations
3.
Wang, Wei, Smita Kothari, Marc Baay, et al.. (2021). Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources. Expert Review of Vaccines. 21(2). 227–240. 9 indexed citations
4.
Russell, Louise B., Sun‐Young Kim, Cristiana M. Toscano, et al.. (2020). Comparison of static and dynamic models of maternal immunization to prevent infant pertussis in Brazil. Vaccine. 39(1). 158–166. 7 indexed citations
5.
Kim, Sun‐Young, Kyung‐Duk Min, Sung-mok Jung, et al.. (2020). Cost-effectiveness of maternal pertussis immunization: Implications of a dynamic transmission model for low- and middle-income countries. Vaccine. 39(1). 147–157. 7 indexed citations
6.
Lucas, A. O., et al.. (2019). A framework for assessing the lifetime economic burden of congenital cytomegalovirus in the United States. Cost Effectiveness and Resource Allocation. 17(1). 21–21. 6 indexed citations
7.
Kim, Sun Young, Louise B. Russell, Sara Tomczyk, et al.. (2017). Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States. Vaccine. 35(45). 6238–6247. 29 indexed citations
8.
Russell, Louise B., Sun Young Kim, Sri Ram Pentakota, et al.. (2017). Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa. Vaccine. 35(49). 6905–6914. 31 indexed citations
9.
Russell, Louise B. & Anushua Sinha. (2016). Strengthening Cost-Effectiveness Analysis for Public Health Policy. American Journal of Preventive Medicine. 50(5). S6–S12. 13 indexed citations
10.
Ozawa, Sachiko, Simrun Grewal, Allison Portnoy, et al.. (2016). Funding gap for immunization across 94 low- and middle-income countries. Vaccine. 34(50). 6408–6416. 15 indexed citations
11.
Jaúregui, Bárbara, Cara Bess Janusz, Andrew Clark, et al.. (2015). ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions. Vaccine. 33. A21–A27. 27 indexed citations
12.
Sinha, Anushua, Soyeon Kim, Gary Ginsberg, et al.. (2012). Economic burden of acute lower respiratory tract infection in South African children. Paediatrics and International Child Health. 32(2). 65–73. 15 indexed citations
13.
Nakamura, Mari, Azadeh Tasslimi, Tracy A. Lieu, et al.. (2011). Cost effectiveness of child pneumococcal conjugate vaccination in middle-income countries. International Health. 3(4). 270–281. 30 indexed citations
14.
Tasslimi, Azadeh, Mari Nakamura, Orin S. Levine, et al.. (2011). Cost effectiveness of child pneumococcal conjugate vaccination in GAVI-eligible countries. International Health. 3(4). 259–269. 16 indexed citations
15.
Constenla, Dagna, Anushua Sinha, Elizabeth Avery Gomez, et al.. (2009). Identifying unit costs for use in regional economic evaluation: an illustrative analysis of childhood pneumococcal conjugate vaccine in Latin America and the Caribbean. Revista Panamericana de Salud Pública. 26(5). 458–468. 10 indexed citations
16.
Valenzuela, María Teresa, Rosalyn O’Loughlin, Fernando de la Hoz, et al.. (2009). The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence. Revista Panamericana de Salud Pública. 25(3). 270–9. 64 indexed citations
17.
Sinha, Anushua, Dagna Constenla, Rosalyn O’Loughlin, et al.. (2008). Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis. Revista Panamericana de Salud Pública. 24(5). 304–313. 49 indexed citations
18.
Sinha, Anushua, Tracy A. Lieu, Lawrence C. Paoletti, Milton C. Weinstein, & Richard Platt. (2005). The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine. 23(24). 3187–3195. 30 indexed citations
19.
Sinha, Anushua, Deborah S. Yokoe, & Richard Platt. (2003). Epidemiology of neonatal infections: experience during and after hospitalization. The Pediatric Infectious Disease Journal. 22(3). 244–250. 29 indexed citations
20.
Sinha, Anushua, Deborah S. Yokoe, & Richard Platt. (2003). Intrapartum antibiotics and neonatal invasive infections caused by organisms other than group B streptococcus. The Journal of Pediatrics. 142(5). 492–497. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026